Denis Ribon


Denis is a founding partner of ArchiMed.

Denis has 20 years of experience in the healthcare sector. After working as a veterinarian and as a strategy consultant at ATKearney, Denis joined 3i where he became global head of their healthcare practice, leading the firm’s healthcare investment and portfolio activity in Europe, North America and Asia.

Denis has been actively involved in the strategic growth and development of companies across all major healthcare sectors. He has served on the board of directors of more than 15 firms, including 10 public and private healthcare companies, such as Quintiles, Labco, iPP, Vétoquinol, Neftys Pharma, Carso, Bioprofile or Cair.

Denis is a member of the Institut Montaigne, a French think tank.

Denis is an administrator of the Eureka Foundation, ArchiMed's non-profit initiative.

Denis graduated from the French Veterinary University of Lyon and holds an MBA from HEC Paris.

His philosophy

Contribute to global health improvement thanks to strategic and capital support to innovative Healthcare players



ArchiMed acquired the majority of Micromed, a franco-italian manufacturer of high-end electrometrical devices in the field of neurology diagnostics.